Press release
Hip Implant Manufacturers Target of Congressional Probe
Nadrich & Cohen LLP reports that the federal government is attempting to implement new legislation that would require enhanced safety testing and tracking of hip implant devices.Los Angeles, CA, December 23, 2011 – In response to growing concerns over the safety and efficacy of metal-on-metal hip implants, members of the U.S. Senate have proposed a new law which would require companies that manufacture these devices to conduct additional safety testing once they are made available to the public.
The new legislation was proposed in an effort to curb the number of lawsuits being filed by consumers who claim they suffered serious injuries after receiving a metal hip replacement device. Johnson & Johnson’s DePuy Orthopedics is currently facing numerous lawsuits from patients who say the company’s ASR and Pinnacle hip implant systems caused serious pain, tissue damage and other complications. Other hip implant manufacturers under fire from angry consumers include Wright Medical Technologies, which produced the now-recalled CONSERVE hip implant system, Biomet, manufacturer of the Magnum hip replacement system and Zimmer, maker of the Durom cup.
The senators who sponsored the bill are hoping that it will allow for greater tracking of the failure rates of these devices. Specifically, the legislation is designed to track those devices which are approved under the U.S. Food and Drug Administration’s 510(k) rule. This system allows for a streamlined approval process in which medical device manufacturers are only required to prove that their product is similar to one already available on the open market. The 510(k) process has been highly criticized in recent years, most notably after the recall of DePuy’s ASR XL Acetabular and ASR Hip Resurfacing Systems in 2010.
As part of their efforts to enhance consumer safety, the senators who proposed the bill also sent letters to five major manufacturers of medical devices, including Zimmer and Johnson & Johnson. The letters included a request for more information about how the safety of hip implants is monitored and how product recalls are handled when they become necessary.
In the case of Johnson & Johnson, the senators wanted to know specifically when the company became aware of problems with its ASR hip implants and how the safety issues were tracked. As of November 2011, the company faced approximately 3,500 lawsuits from plaintiffs alleging serious injury after receiving one of these devices.
If you or a loved one has experienced serious pain, swelling, infection, tissue damage or other negative side effects that you believe were caused by a metal-on-metal hip implant, you need to contact an experienced personal injury attorney to discuss your case. Prominent national law firm Nadrich & Cohen LLP is currently reviewing hip implant claims from patients in all 50 states. No-cost, no-obligation case evaluations are available by calling 1-800-722-0765 or visiting our hip injury resource center at www.DePuyHipReplacementLawyers.net.
Nadrich & Cohen LLP is a national law firm specializing in representing clients nationwide who’ve been injured by defective medical devices, harmful prescription drugs, faulty products, traffic accidents, workplace accidents and dog bites. To learn more about our firm, visit www.PersonalInjuryLawCal.com.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
www.personalinjurylawcal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hip Implant Manufacturers Target of Congressional Probe here
News-ID: 205333 • Views: …
More Releases from Nadrich & Cohen LLP
Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation.
Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed…
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots.
Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.…
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants.
Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems.
The two-day panel, which is expected…
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country.
Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the…
More Releases for Johnson
Sarcoma Treatment Market Is Booming Worldwide 2025-2032 | Amgen Inc., Johnson & …
Coherent Market Insights has released a statistical report titled "Sarcoma Treatment Market Recent Trends, In-depth Analysis, Size, and Forecast 2025-2032." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the…
Siltuximab Market Analysis By Top Keyplayers - Johnson & Johnson
The "Siltuximab Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Siltuximab Market, 2024-2031
Verified Market Research's most recent report, "Siltuximab Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Artificial Limbs and Joints Market Expected to reach a Hugh Growth by 2031 | Art …
Artificial Limbs and Joints Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report…
Artificial Limbs and Joints Industry to Witness Massive Growth (2024-2031) | Art …
Artificial Limbs and Joints Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Artificial Limbs and Joints market emerge as the sector's next great thing? To discover the answer, look at the Artificial Limbs and…
Ebola Vaccine Market | CanSino Biologics Inc, Johnson & Johnson, Merck,
The global ebola vaccine market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the ebola vaccine market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Medical Devices for Diagnostics in Vitro Market is Thriving Worldwide with Top K …
Market Overview -
According To A Recent Report Published By QYResearch, The Global Medical Devices for Diagnostics in Vitro Market Is Heading Towards The Inclined Path Of Growth With An Exceptional Growth Rate Over The Forecast Period Of 2023-2029. The Report Published Covers All The Aspects Of The Medical Devices for Diagnostics in Vitro Industry, Starting From The Industry Standard, Segments In Which The Industry Operates, Regional…